ROS Signalling of inflammatory cytokines during trypanosoma cruzi infection

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 153-170

  Gupta, Shivali ^a   Dhiman, Monisha ^a   Wen, Jian jun ^a   Garg, Nisha Jain ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Chagas; Cytokines; Inflammation; Oxidative stress; ROS; Trypanosoma cruzi

Indexed keywords

ARACHIDONIC ACID; ARGININE; CARDIOTROPHIN 1; CYTOCHROME P450; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; XANTHINE OXIDASE;

ARACHIDONIC ACID METABOLISM; BOOK; CARDIOVASCULAR DISEASE; CD8+ T LYMPHOCYTE; CHAGAS DISEASE; ELECTRON TRANSPORT; ENDOTHELIUM CELL; FENTON REACTION; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; INFLAMMATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL;

TRYPANOSOMA CRUZI;

EID: 80052145820     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00007-4     Document Type: Chapter

References (118)

1. Alvarez M.N., Piacenza L., Irigoin F., Peluffo G., Radi R. Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 2004, 432:222-232.
2. Andrew P.J., Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 1999, 43:521-531.
3. Arnaiz M.R., Fichera L.E., Postan M. Cardiac myocyte hypertrophy and proliferating cell nuclear antigen expression in Wistar rats infected with Trypanosoma cruzi. J. Parasitol. 2002, 88:919-925.
4. Aukrust P., Berge R.K., Ueland T., Aaser E., Damas J.K., Wikeby L., et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J. Am. Coll. Cardiol. 2001, 37:485-491.
5. Aukrust P., Gullestad L., Ueland T., Damas J.K., Yndestad A. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann. Med. 2005, 37:74-85.
6. Ba X., Gupta S., Davidson M., Garg N.J. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J. Biol. Chem. 2010, 285:11596-11606.
7. Balakumar P., Singh M. Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy. Methods Find. Exp. Clin. Pharmacol. 2006, 28:683-689.
8. Belaiba R.S., Djordjevic T., Petry A., Diemer K., Bonello S., Banfi B., et al. NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 2007, 42:446-459.
9. Berry C.E., Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J. Physiol. 2004, 555:589-606.
10. Cardoni R.L., Antunez M.I., Morales C., Nantes I.R. Release of reactive oxygen species by phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1997, 56:329-334.
11. Carrasco Guerra H.A., Palacios-Pru E., Dagert de Scorza C., Molina C., Inglessis G., Mendoza R.V. Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage. Am. Heart J. 1987, 113:716-724.
12. Chandrasekar B., Melby P.C., Troyer D.A., Colston J.T., Freeman G.L. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am. J. Pathol. 1998, 152:925-934.
13. Chandrasekar B., Colston J.T., de la Rosa S.D., Rao P.P., Freeman G.L. TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem. Biophys. Res. Commun. 2003, 303:1152-1158.
14. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 2003, 278(38):36027-36031.
15. Chen M.S., Xu F.P., Wang Y.Z., Zhang G.P., Yi Q., Zhang H.Q., Luo J.D. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis. J. Mol. Cell. Cardiol. 2004, 37:889-896.
16. Cohen G. Enzymatic/nonenzymatic sources of oxyradicals and regulation of antioxidant defenses. Ann. N. Y. Acad. Sci. 1994, 738:8-14.
17. Cunha-Neto E., Kalil J. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001, 34:187-192.
18. Cunha-Neto E., Rizzo L.V., Albuquerque F., Abel L., Guilherme L., Bocchi E., et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz. J. Med. Biol. Res. 1998, 31:133-137.
19. Cunha-Neto E., Dzau V.J., Allen P.D., Stamatiou D., Benvenutti L., Higuchi M.L., et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am. J. Pathol. 2005, 167:305-313.
20. Curtsinger J.M., Schmidt C.S., Mondino A., Lins D.C., Kedl R.M., Jenkins M.K., Mescher M.F. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 1999, 162:3256-3262.
21. D'Autreaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8:813-824.
22. Damas J.K., Gullestad L., Aass H., Simonsen S., Fjeld J.G., Wikeby L., et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure-modulatory effect of intravenous immunoglobulin. J. Am. Coll. Cardiol. 2001, 38:187-193.
23. de Oliveira T.B., Pedrosa R.C., Filho D.W. Oxidative stress in chronic cardiopathy associated with Chagas disease. Int. J. Cardiol. 2007, 116:357-363.
24. Dhingra S., Sharma A.K., Singla D.K., Singal P.K. p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3524-H3531.
25. Dhiman M., Garg N.J. NADPH oxidase inhibition ameliorates T cruzi induced myocarditis during Chagas disease. Journal of Pathology 2011, (in press).
26. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20:55-72.
27. Euler-Taimor G., Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc. Res. 2006, 69:15-25.
28. Frangogiannis N.G., Dewald O., Xia Y., Ren G., Haudek S., Leucker T., et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 2007, 115:584-592.
29. Garg N., Popov V.L., Papaconstantinou J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim. Biophys. Acta 2003, 1638:106-120.
30. Garg N., Bhatia V., Gerstner A., deFord J., Papaconstantinou J. Gene expression analysis in mitochondria from chagasic mice: alterations in specific metabolic pathways. Biochem. J. 2004, 381:743-752.
31. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 1992, 22:2501-2506.
32. Guggilam A., Haque M., Kerut E.K., McIlwain E., Lucchesi P., Seghal I., Francis J. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H599-H609.
33. Gullestad L., Aukrust P. Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am. J. Cardiol. 2005, 95:17C-23C. discussion 38C-40C.
34. Gupta S., Garg N.J. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice. PLoS Negl. Trop. Dis. 2010, 4:e797.
35. Gupta S., Bhatia V., Wen J.J., Wu Y., Huang M.H., Garg N.J. Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radic. Biol. Med. 2009, 47:1414-1421.
36. Gupta S., Wen J.J., Garg N.J. Oxidative stress in Chagas disease. Interdiscip. Perspect. Infect. Dis. 2009, 2009, Article ID 190354, 8 pages. doi:10.1155/2009/190354.
37. Hall B.S., Tam W., Sen R., Pereira M.E. Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection. Mol. Biol. Cell 2000, 11:153-160.
38. Hardison J.L., Wrightsman R.A., Carpenter P.M., Kuziel W.A., Lane T.E., Manning J.E. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 2006, 74:135-143.
39. Hardison J.L., Wrightsman R.A., Carpenter P.M., Lane T.E., Manning J.E. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect. Immun. 2006, 74:125-134.
40. Hensley K., Robinson K.A., Gabbita S.P., Salsman S., Floyd R.A. Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 2000, 28:1456-1462.
41. Hernandez S.M., Kolliker-Frers R.A., Sanchez M.S., Razzitte G., Britos R.D., Fuentes M.E., Schwarcz de Tarlovsky M.N. Antiproliferative effect of sera from chagasic patients on Trypanosoma cruzi epimastigotes. Involvement of xanthine oxidase. Acta Trop. 2009, 109:219-225.
42. Higuchi Mde L., Gutierrez P.S., Aiello V.D., Palomino S., Bocchi E., Kalil J., et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch. A Pathol. Anat. Histopathol. 1993, 423:157-160.
43. Higuchi M.D., Ries M.M., Aiello V.D., Benvenuti L.A., Gutierrez P.S., Bellotti G., Pileggi F. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 1997, 56:485-489.
44. Holscher C., Mohrs M., Dai W.J., Kohler G., Ryffel B., Schaub G.A., et al. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 2000, 68:4075-4083.
45. Hori M., Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009, 81:457-464.
46. Houston M.C. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther. Adv. Cardiovasc. Dis. 2010, 4:165-183.
47. Huang H., Calderon T.M., Berman J.W., Braunstein V.L., Weiss L.M., Wittner M., Tanowitz H.B. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect. Immun. 1999, 67:5434-5440.
48. Huang H., Petkova S.B., Cohen A.W., Bouzahzah B., Chan J., Zhou J.N., et al. Activation of transcription factors AP-1 and NF-kappa B in murine chagasic myocarditis. Infect. Immun. 2003, 71:2859-2867.
49. Ichihara S., Noda A., Nagata K., Obata K., Xu J., Ichihara G., et al. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Cardiovasc. Res. 2006, 69:726-735.
50. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 1999, 85:357-363.
51. Kayama H., Takeda K. The innate immune response to Trypanosoma cruzi infection. Microbes Infect. 2010, 12:511-517.
52. Khaper N., Bryan S., Dhingra S., Singal R., Bajaj A., Pathak C.M., Singal P.K. Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid. Redox Signal. 2010, 13:1033-1049.
53. Kuster G.M., Pimentel D.R., Adachi T., Ido Y., Brenner D.A., Cohen R.A., et al. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 2005, 111:1192-1198.
54. Laura P.A., Michela D.R., Silvia M., Marcello P., Gerarda P., Alberto A., Luca P. Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling. Mediat. Inflamm. 2010, 2010, Article ID 974694, 8 pages. doi:10.1155/2010/974694.
55. Li J.M., Gall N.P., Grieve D.J., Chen M., Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002, 40:477-484.
56. Liaudet L., Vassalli G., Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci. 2009, 14:4809-4814.
57. Lipinski S., Till A., Sina C., Arlt A., Grasberger H., Schreiber S., Rosenstiel P. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. J. Cell Sci. 2009, 122:3522-3530.
58. Macao L.B., Filho D.W., Pedrosa R.C., Pereira A., Backes P., Torres M.A., Frode T.S. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. Int. J. Cardiol. 2007, 123:43-49.
59. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000, 102:3003-3008.
60. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., et al. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 2005, 191:627-636.
61. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 2002, 91:988-998.
62. Marczin N., El-Habashi N., Hoare G.S., Bundy R.E., Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch. Biochem. Biophys. 2003, 420:222-236.
63. Matsuzawa A., Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid. Redox Signal. 2005, 7:472-481.
64. Melo R.C., Fabrino D.L., D'Avila H., Teixeira H.C., Ferreira A.P. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol. Int. 2003, 27:853-861.
65. Miller M.J., Wrightsman R.A., Stryker G.A., Manning J.E. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. J. Immunol. 1997, 158:5330-5337.
66. Mukherjee S., Belbin T.J., Spray D.C., Iacobas D.A., Weiss L.M., Kitsis R.N., et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol. Res. 2003, 91:187-196.
67. Munoz-Fernandez M.A., Fernandez M.A., Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 1992, 33:35-40.
68. Nakagami H., Takemoto M., Liao J.K. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 2003, 35:851-859.
69. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998, 98:794-799.
70. Neumann D.A., Lane J.R., Allen G.S., Herskowitz A., Rose N.R. Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis?. Clin. Immunol. Immunopathol. 1993, 68:181-190.
71. Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 2004, 94:1543-1553.
72. Pacher P., Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 2008, 173:2-13.
73. Palacios-Pru E., Carrasco H., Scorza C., Espinoza R. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am. J. Trop. Med. Hyg. 1989, 41:29-40.
74. Pape K.A., Khoruts A., Mondino A., Jenkins M.K. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J. Immunol. 1997, 159:591-598.
75. Parada H., Carrasco H.A., Anez N., Fuenmayor C., Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int. J. Cardiol. 1997, 60:49-54.
76. Pereira Barretto A.C., Mady C., Arteaga-Fernandez E., Stolf N., Lopes E.A., Higuchi M.L., et al. Right ventricular endomyocardial biopsy in chronic Chagas' disease. Am. Heart J. 1986, 111:307-312.
77. Perez-Fuentes R., Guegan J.F., Barnabe C., Lopez-Colombo A., Salgado-Rosas H., Torres-Rasgado E., et al. Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals. Int. J. Parasitol. 2003, 33:293-299.
78. Petkova S.B., Huang H., Factor S.M., Pestell R.G., Bouzahzah B., Jelicks L.A., et al. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 2001, 31:499-511.
79. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J. Biochem. Mol. Biol. 2003, 36:95-109.
80. Rahman I., MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 2000, 28:1405-1420.
81. Reed S.G. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 1988, 140:4342-4347.
82. Reed S.G., Brownell C.E., Russo D.M., Silva J.S., Grabstein K.H., Morrissey P.J. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 1994, 153:3135-3140.
83. Rossi M.A., Ramos S.G., Bestetti R.B. Chagas' heart disease: clinical-pathological correlation. Front. Biosci. 2003, 8:e94-e109.
84. Saavedra E., Herrera M., Gao W., Uemura H., Pereira M.A. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J. Exp. Med. 1999, 190:1825-1836.
85. Samudio M., Montenegro-James S., de Cabral M., Martinez J., Rojas de Arias A., Woroniecky O., James M.A. Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Trop. 1998, 69:89-97.
86. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., et al. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 2001, 89:661-669.
87. Satoh M., Ogita H., Takeshita K., Mukai Y., Kwiatkowski D.J., Liao J.K. Requirement of Rac1 in the development of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 2006, 103:7432-7437.
88. Silva J.S., Vespa G.N., Cardoso M.A., Aliberti J.C., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 1995, 63:4862-4867.
89. Silva G.K., Gutierrez F.R., Guedes P.M., Horta C.V., Cunha L.D., Mineo T.W., et al. Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection. J. Immunol. 2010, 184:1148-1152.
90. Souza P.E., Rocha M.O., Rocha-Vieira E., Menezes C.A., Chaves A.C., Gollob K.J., Dutra W.O. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect. Immun. 2004, 72:5283-5291.
91. Stumpf C., Seybold K., Petzi S., Wasmeier G., Raaz D., Yilmaz A., et al. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. Eur. J. Heart Fail. 2008, 10:733-739.
92. Sun Y., Ahokas R.A., Bhattacharya S.K., Gerling I.C., Carbone L.D., Weber K.T. Oxidative stress in aldosteronism. Cardiovasc. Res. 2006, 71:300-309.
93. Takemoto M., Node K., Nakagami H., Liao Y., Grimm M., Takemoto Y., et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J. Clin. Invest. 2001, 108:1429-1437.
94. Talvani A., Ribeiro C.S., Aliberti J.C., Michailowsky V., Santos P.V., Murta S.M., et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2000, 2:851-866.
95. Tanaka K., Honda M., Takabatake T. Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J. Am. Coll. Cardiol. 2001, 37:676-685.
96. Tanowitz H.B., Gumprecht J.P., Spurr D., Calderon T.M., Ventura M.C., Raventos-Suarez C., et al. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J. Infect. Dis. 1992, 166:598-603.
97. Tatsumi T., Matoba S., Kawahara A., Keira N., Shiraishi J., Akashi K., et al. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J. Am. Coll. Cardiol. 2000, 35:1338-1346.
98. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
99. Teixeira M.M., Gazzinelli R.T., Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 2002, 18:262-265.
100. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L1005-L1028.
101. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., Mann D.L. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996, 93:704-711.
102. Tse H.M., Milton M.J., Piganelli J.D. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic. Biol. Med. 2004, 36:233-247.
103. Turrens J.F. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003, 552:335-344.
104. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 2002, 4:405-414.
105. Uyemura S.A., Albuquerque S., Curti C. Energetics of heart mitochondria during acute phase of Trypanosoma cruzi infection in rats. Int. J. Biochem. Cell Biol. 1995, 27:1183-1189.
106. Uyemura S.A., Jordani M.C., Polizello A.C., Curti C. Heart FoF1-ATPase changes during the acute phase of Trypanosoma cruzi infection in rats. Mol. Cell. Biochem. 1996, 165:127-133.
107. Van Voorhis W.C. Co-culture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J. Immunol. 1992, 148:239-248.
108. Vyatkina G., Bhatia V., Gerstner A., Papaconstantinou J., Garg N. Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochim. Biophys. Acta 2004, 1689:162-173.
109. Wei G.C., Sirois M.G., Qu R., Liu P., Rouleau J.L. Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat. J. Cardiovasc. Pharmacol. 2002, 39:842-850.
110. Weintraub N.L. Nox response to injury. Arterioscler. Thromb. Vasc. Biol. 2002, 22:4-5.
111. Wen J.J., Garg N.J. Mitochondrial generation of reactive oxygen species is enhanced at the Q(o) site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: beneficial effects of an antioxidant. J. Bioenerg. Biomembr. 2008, 40:587-598.
112. Wen J.-J., Vyatkina G., Garg N. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic. Biol. Med. 2004, 37:1821-1833.
113. Wen J.-J., Bhatia V., Popov V.L., Garg N.J. Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas disease. Am. J. Pathol. 2006, 169:1953-1964.
114. Wen J.J., Gupta S., Guan Z., Dhiman M., Condon D., Lui C., Garg N.J. Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats. J. Am. Coll. Cardiol. 2010, 55:2499-2508.
115. Wu S., Gao J., Ohlemeyer C., Roos D., Niessen H., Kottgen E., Gessner R. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic. Biol. Med. 2005, 39:1601-1610.
116. Xiao L., Pimental D.R., Amin J.K., Singh K., Sawyer D.B., Colucci W.S. MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 2001, 33:779-787.
117. Xiao L., Pimentel D.R., Wang J., Singh K., Colucci W.S., Sawyer D.B. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 2002, 282:C926-C934.
118. Zacks M.A., Wen J.J., Vyatkina G., Bhatia V., Garg N. An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress. An. Acad. Bras. Cienc. 2005, 77:695-715.